The Journal of Clinical Cancer
Research and Therapeutic Applications is an international, peer-reviewed,
open-access journal committed to publishing high-quality research and
innovative findings in all areas of Cancer research and its therapeutics sciences.
The journal was established with a vision to serve as a premier platform where
clinicians, researchers, academicians, and healthcare professionals can share
their discoveries, exchange knowledge, and advance the understanding of various
types of cancers.
In todayβs rapidly evolving medical
and scientific landscape, cancer research has entered a transformative era
driven by precision medicine, molecular diagnostics, and innovative therapeutic
strategies. Cancer remains a major global health challenge, demanding
continuous advancements in early detection, personalized treatment, and
translational research to improve patient survival and quality of life.
Journal of Clinical Cancer Research
and Therapeutic Applications is dedicated to publishing high-quality research
that bridges laboratory discoveries with clinical implementation. The journal
provides a platform for clinicians, oncologists, researchers, and healthcare
professionals to disseminate original research, clinical studies, translational
investigations, and therapeutic innovations across all cancer types.
The journal welcomes contributions in
areas including clinical oncology, molecular and cellular cancer biology,
immunotherapy, targeted therapies, chemotherapy, radiotherapy, precision
oncology, biomarker discovery, clinical trials, and emerging therapeutic
technologies. By fostering interdisciplinary collaboration and evidence-based
practice, the journal aims to contribute meaningfully to the advancement of
cancer science and the development of effective therapeutic applications
worldwide.
The aim of the Journal of Clinical
Cancer Research and Therapeutic Applications is to promote scientific
advancement and provide a credible, peer-reviewed platform for the
dissemination of high-quality research in clinical oncology and translational
cancer science. The journal is committed to fostering collaboration among
clinicians, researchers, and healthcare professionals dedicated to improving
cancer prevention, diagnosis, treatment, and patient outcomes worldwide.
The journal covers a broad scope
including clinical oncology, medical oncology, surgical oncology, radiation
oncology, molecular and cellular cancer biology, tumor immunology, precision
medicine, targeted therapies, immunotherapy, chemotherapy advancements,
radiotherapeutic innovations, biomarker discovery, cancer genetics, and
translational research. We also welcome research on early detection strategies,
clinical trials, novel drug development, personalized therapeutic approaches,
cancer epidemiology, survivorship care, palliative medicine, and emerging
technologies such as artificial intelligence in oncology.
By encouraging the publication of original research articles, systematic reviews, meta-analyses, case reports, clinical studies, and innovative therapeutic approaches, the journal seeks to bridge the gap between laboratory discoveries and real-world clinical application. Through scientific rigor and interdisciplinary collaboration, the journal aims to contribute meaningfully to global cancer research efforts and enhance the quality of care and survival outcomes for patients affected by cancer.
Authors can submit their manuscripts
through our Online https://thesciencemedia.com/journal-of-clinical-cancer-research-and-therapeutic-applications/submit-manuscript.
directly via email to "clinicalcancerres@sciencemediajournals.com".
All submissions will undergo a rigorous peer-review process to ensure quality
and originality.
The Science Media Online Publishing Group is an independent, international publisher of peer-reviewed scientific journals, specializing in clinical and medical research.
βCopyright 2025 The Science Media. All rights reserved